Urologic Oncology Services · NYC
Prostate, Bladder & Kidney Cancer Treatment in NYC
A complete range of treatment options for prostate cancer, bladder and upper tract urothelial cancer, and kidney cancer, delivered at NYU Langone Health in Manhattan. Each recommendation is tailored to the patient's cancer biology, anatomy, and priorities.
Services are grouped by cancer type. Most patients start with the Where to Start section, then scroll to the section that matches their diagnosis: Prostate Cancer, Bladder & Upper Tract Cancer, or Kidney Cancer.
Where to Start
Most prostate cancer decisions are not urgent. The right starting point is often a structured surveillance program or an independent second opinion before any treatment is chosen.
Active Surveillance
Structured monitoring for low-risk and favorable intermediate-risk prostate cancer with PSA, multiparametric MRI, and protocolized transperineal biopsy.
Explore Surveillance →Prostate Cancer Second Opinion NYC
Independent review of PSA, MRI, biopsy, and any proposed treatment plan from a urologic oncologist who performs the full spectrum of treatments.
Book a Second Opinion →Prostate Cancer
Full spectrum of prostate cancer care, from focal therapy to robotic surgery and radiation preparation, all performed by the same surgeon.
Focal Therapy
HIFU Focal Therapy
High-intensity focused ultrasound via the Focal One machine. Incisionless, organ-sparing, outpatient procedure under general anesthesia.
Explore HIFU →Cryoablation
Cryoprobes placed transperineally to freeze the cancer-bearing region. Primary and salvage cryoablation for radio-recurrent disease.
Explore Cryo →Aliya PEF Therapy
Pulsed electric field ablation, non-thermal focal therapy. First surgeon at NYU Langone and in Manhattan to perform Aliya PEF for prostate cancer.
Explore Aliya PEF →Robotic Surgery
Precision Robotic Prostatectomy
Long urethral-sparing technique designed for early urinary control. Same-day discharge for most patients.
Explore Surgery →Not Sure Which Treatment?
Book a consultation to walk through every reasonable option for your specific cancer.
Book a Consultation →Diagnosis & Radiation Support
Transperineal MRI Fusion Biopsy
500+ per year, office-based under local anesthesia. Published low pain scores. Near-zero infection risk.
Explore Biopsy →Spacers & Fiducials for Radiation
Office-based Barrigel and SpaceOAR rectal spacers plus gold fiducial placement for CyberKnife, MR-Linac, and IGRT.
Explore Radiation Prep →Bladder & Upper Tract Cancer
Full spectrum of urothelial cancer care, from TURBT and intravesical therapy to robotic cystectomy and kidney-sparing options for upper tract disease.
TURBT & NMIBC Therapy
TURBT with blue light cystoscopy plus the full menu of intravesical therapies: BCG, BRIDGE gem-doce, Anktiva, Adstiladrin, Keytruda, Inlexzo, and Zusduri.
Explore TURBT →Robotic Radical Cystectomy
Robotic cystectomy with intracorporeal urinary diversion, ileal conduit or orthotopic neobladder. Published peer-reviewed work on intracorporeal technique.
Explore Cystectomy →Nephroureterectomy & UTUC
Robotic nephroureterectomy for upper tract urothelial cancer, plus kidney-sparing endoscopic management and Jelmyto for selected low-grade UTUC.
Explore UTUC →Kidney Cancer
Robotic partial and radical nephrectomy for kidney tumors, including complex cases with caval thrombus, performed at NYU Langone, Manhattan.
Robotic Partial & Radical Nephrectomy
Robotic kidney surgery via retroperitoneal or transperitoneal approaches. Caval thrombectomy for IVC tumor thrombus. Signatera MRD monitoring.
Explore Kidney Surgery →Kidney Mass or Small Renal Mass?
Second opinion and surgical evaluation for new kidney tumors. Bring imaging and labs.
Book a Consultation →Focal Therapy for Prostate Cancer
Focal therapy is a category of minimally invasive prostate cancer treatments that destroy only the cancerous portion of the prostate while preserving healthy tissue, the urethra, neurovascular bundles, and surrounding anatomy. The goal is to control the cancer while preserving urinary, sexual, and bowel function, and keeping every future treatment option open.
Dr. Wei Phin Tan offers HIFU, cryoablation, and Aliya pulsed electric field therapy at NYU Langone Health, Main Campus in Manhattan. Multiple focal therapy tools under one surgeon. He personally performs 70+ focal therapies per year, part of NYU Langone's program performing 250+ procedures annually, one of the highest-volume focal therapy programs in New York City.
HIFU vs. Cryoablation vs. Robotic Prostatectomy vs. Radiation
Radiation includes EBRT (external beam), SBRT (stereotactic body radiation), and brachytherapy.
A simplified side-by-side. Every patient is different, this table is a starting point for a conversation, not a substitute for one. What the right option is for you depends on your cancer biology, anatomy, urinary function, and priorities.
| Factor | HIFU | Cryoablation | Robotic Prostatectomy | Radiation |
|---|---|---|---|---|
| Approach | Focused ultrasound heat delivered through a transrectal probe | Cryoprobes placed through the perineum to freeze the cancer | Entire prostate removed robotically through several small incisions | External beam, SBRT, or brachytherapy delivered over days to weeks |
| Anesthesia & Setting | General anesthesia; outpatient procedure | General anesthesia; outpatient procedure | General anesthesia; same-day discharge | EBRT/SBRT usually require no anesthesia; brachytherapy usually requires anesthesia |
| Treatment Time | Usually 60 to 90 minutes | Usually 1 to 2 hours | Usually 2 to 3 hours | SBRT is commonly 5 sessions; EBRT is commonly several weeks; brachytherapy may be a single procedure or combined with EBRT |
| Recovery | Normal activity in several days; catheter usually 5 to 7 days | Normal activity in about 1 week; catheter usually 5 to 7 days | Light activity within days; catheter usually 5 to 7 days; return to normal activity over several weeks | Minimal downtime; urinary and bowel irritation can occur during treatment, with fatigue building over time |
| Urinary Side Effects | Leakage is uncommon after focal HIFU, though temporary urgency, frequency, weak stream, or retention can occur | Leakage is uncommon after focal cryoablation, though temporary urgency, frequency, weak stream, or retention can occur | Dr. Tan uses a urethral-sparing robotic technique designed to preserve early urinary control. Many patients regain continence soon after catheter removal, although temporary leakage can still occur, particularly with a very large median lobe or more complex anatomy | Radiation can cause urgency, frequency, burning, weak stream, and sometimes urge incontinence, which may occur during treatment or develop years later |
| Erectile Function Preservation | Often favorable when treatment is away from the nerve bundles | Often favorable when the nerve bundles are outside the ice ball; lower with whole-gland treatment | Depends on baseline function, age, cancer location, and nerve-sparing; recovery can take 12 to 24 months | Often declines gradually over 2 to 5 years; risk is higher with age, baseline ED, and ADT |
| Cancer Control | Good for well-selected, MRI-visible localized lesions; repeat treatment is possible | Good for well-selected localized lesions; repeat treatment is possible | Established whole-gland treatment with final pathology and staging information | Established long-term cancer control across risk groups |
| Salvage if It Fails | Repeat HIFU, cryoablation, radiation, or surgery may be possible | Repeat cryoablation, HIFU, radiation, or surgery may be possible | Salvage radiation is standard when indicated | Surgery or focal therapy after radiation is possible but technically harder and more morbid |
| Best For | Posterior, mid-gland, MRI-visible lesions in well-selected patients | Selected focal cases, larger glands, and salvage after radiation | Patients wanting definitive whole-gland removal, final pathology, and staging information | Men who prefer non-surgical treatment, patients at higher surgical risk, and many intermediate- or high-risk cases |
| Insurance / Medicare Coverage | Variable; often inconsistent for primary focal therapy | Usually covered for whole-gland or salvage settings; focal primary cryo coverage varies by payer | Generally covered | Generally covered |
These comparisons are general ranges based on published experience and clinical practice. Your individual risks depend on your cancer, anatomy, prior treatments, and baseline urinary and sexual function. Dr. Tan will personalize these estimates at consultation.
Not Sure Which Treatment Is Right for You?
The best treatment isn't always the most aggressive one, or the newest one. Dr. Tan's consultation walks through the full spectrum of options so you can decide alongside, not be pushed into, a plan.
Contact the Practice